Lisa Kopas is a Respiratory physician affiliated with Methodist Hospital. OpenAlex indexes 23 publications with 597 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6560 Fannin St Ste 1632
Houston, TX 770302734
Telephone
713-255-4000Provider last certified this registry record 16 Nov 2023.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202516 payments$14,205openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20256 payments
- INTUITIVE SURGICAL, INC.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
67.8%Corticosteroid36.6%Trelegy Ellipta35%Breo Ellipta23%Fluticasone Propionate13%Arnuity Ellipta9%Dulera7%Symbicort6%Breyna3%Budesonide-Formoterol Fumarate2%Qvar Redihaler2%Breztri Aerosphere1%Part D<11 patientsLeukotriene Receptor Antagonist13.1%Montelukast Sodium100%Part D≥105 patients+ 4 more classes in this area
Anti-infectives
16.1%Macrolide Antimicrobial8.4%Azithromycin89%Clarithromycin11%Part D<11 patientsFluoroquinolone Antibacterial2%Levofloxacin100%Part D≥47 patients+ 7 more classes in this area
Metabolism & gastrointestinal
9.7%Corticosteroid8%Prednisone100%Part D≥111 patientsH2 blocker0.8%Famotidine100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Impact of Intraoperative C-arm 3D Imaging on the Diagnostic Yield of Robotic Shape-Sensing Navigation Transbronchial Biopsy
Annals of Thoracic Surgery Short Reports
2025 - Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr® valves
Respiratory Medicine
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Gerald Lawrie, MD
Methodist Hospital
Eric Peden, MD
Methodist Hospital
Randall Wolf, MD
Methodist Hospital
Jeffrey Vrabec, MD
Methodist Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”